These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6876475)

  • 1. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunotherapy of established tumors with syngeneic antitumor serum in combination with immunopotentiators.
    Shinoda H; Yamazaki M; Mizuno D
    Gan; 1977 Oct; 68(5):567-71. PubMed ID: 590681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
    Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of syngeneic antitumor serum on mammary tumor in a syngeneic host.
    Shinoda H; Yamazaki M; Mizuno D
    Gan; 1977 Oct; 68(5):561-5. PubMed ID: 590680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of Listeria factor Ei, BCG vaccine and a combination of both on the growth of experimental syngeneic tumors in inbred mice].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8-9):230-7. PubMed ID: 2562579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL; Boyer CM; Purnell DM
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step mechanism of macrophage-mediated tumor lysis in vitro.
    Yamazaki M; Shinoda H; Suzuki Y; Mizuno D
    Gan; 1976 Oct; 67(5):741-5. PubMed ID: 797628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.
    Shimada S; Yano O; Inoue H; Kuramoto E; Fukuda T; Yamamoto H; Kataoka T; Tokunaga T
    J Natl Cancer Inst; 1985 Mar; 74(3):681-8. PubMed ID: 3856070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction.
    Fisher B; Hanlon J; Gebhardt M; Linta J; Saffer E
    Cancer Res; 1978 Jan; 38(1):38-41. PubMed ID: 618581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular cytotoxicity and serum inhibition in normal mice following transfer of xenogeneic tumor-sensitized cells.
    Fisher B; Wolmark N; Saffer EA
    Cancer Res; 1979 Dec; 39(12):4772-6. PubMed ID: 498106
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of cancer: induction of tumor immunity with a mixture of tumor cell-BCG, and the effect of intratumor injection of BCG and of nonliving BCG preparation.
    Tanaka T; Saito T
    Gan; 1975 Dec; 66(6):631-40. PubMed ID: 1225716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An attempt to control the growth of syngeneic experimental tumors in inbred mice using Listeria factor Ei, BCG vaccine and a combination of both].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8):230-7. PubMed ID: 2617123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM; Wysocka M; Kurzawa HL; Lee WM; Trinchieri G; Eck SL
    Cancer Res; 1995 Nov; 55(21):4980-7. PubMed ID: 7585539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.